Short duration neoadjuvant chemotherapy followed by radiotherapy for advanced carcinoma of the cervix: Results and prognostic variables

European Journal of Gynaecological Oncology

Volumn 24, Issue 2, 2003, Pages 163-168

  Seoud, M ^a   Geara, F B ^a   Shamseddine, A ^a   Salem, Z ^a   Khalil, A ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Cervical cancer; Neoadjuvant chemotherapy; Radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; VINCRISTINE;

ADULT; ADVANCED CANCER; AGED; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SIZE; CANCER SURVIVAL; CLINICAL ARTICLE; COBALT THERAPY; CONFERENCE PAPER; FEMALE; GYNECOLOGIC CANCER; HUMAN; HYSTERECTOMY; LUNG TOXICITY; PROGNOSIS; SIDE EFFECT; TREATMENT OUTCOME; UTERINE CERVIX CARCINOMA;

EID: 0037248704     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (47)

1. Adelstein D. J., Saxton J. P., Lavertu P. et al.: "A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: preliminary results". Head Neck, 1997, 19, 567.
2. Adelstein D. J.: "Induction chemotherapy in head and neck cancer". Hematol. Oncol. Clin. No. Am., 1999, 13, 689.
3. Bourhis J., Wilson G., Wibault P. et al.: "Rapid tumor cell proliferation after induction chemotherapy in oropharyngeal cancer". Laryngoscope, 1994, 104, 468.
4. Bourhis J., Pignon J. P.: "Meta-analyses in head and neck squamous cell carcinoma. What is the role of chemotherapy?". Hematol. Oncol. Clin. No. Am., 1999, 13, 769.
5. Chang T. C., Lai C. H., Hong J. H. et al.: "Randomized trial of neoadjuvant cisplatin, vincristine, bleomycin, and radical hysterectomy versus radiation therapy for bulky stage IB and IIA cervical cancer". J. Clin. Oncol., 2000, 18, 1740.
6. Chauvergne J., Rohart J., Heron J. F. et al.: "Randomized trial of initial chemotherapy in 151 locally advanced carcinoma of the cervix (T2b-N1, T3b, MO)". Bull. Cancer, 1990, 77, 1007.
7. Chauvergne J., Lhomme C., Rohart J. et al.: "Neoadjuvant chemotherapy of stage IIb or III cancers of the uterine cervix. Long-term results of a multicenter randomized trial of 151 patients". Bull. Cancer, 1993, 80, 1069.
8. Chiarugi V., Magnelli L., Chiarugi A. et al.: "Hypoxia induces pivotal tumor angiogenesis control factors including p53, vascular endothelial growth factor and the NFkappaB-dependent inducible nitric oxide synthase and cyclooxygenase-2". J. Cancer. Res. Clin. Oncol., 1999, 125, 525.
9. Eifel P. J., Morris M., Wharton J. T. et al.: "The influence of tumor size and morphology on the outcome of patients with FIGO stage IB squamous cell carcinoma of the uterine cervix". Int. J. Radiat. Oncol. Biol. Phys., 1994, 29, 9.
10. El-Sayed S., Nelson N.: "Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region. A meta-analysis of prospective and randomized trials". J. Clin. Oncol., 1996, 14, 838.
11. Filtenborg T. A., Hansen H. H., Aage Engelholm et al.: "A phase II study of ifosfamide, carboplatin and cisplatin in advanced and recurrent squamous cell carcinoma of the uterine cervix". Ann. Oncol., 1993, 4, 485.
12. Giaccia A. J.: "Hypoxic stress proteins". Sem. in Rad. Onc., 1996, 6, 46.
13. Green J. A., Kirwan J. M., Tierney J. F. et al.: "Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis". Lancet, 2001, 358 (9284), 781.
14. Herscher L. L., Cook J. A., Pacelli R. et al.: "Principles of chemoradiation: theoretical and practical considerations". Oncology (Huntingt), 1999, 13 (Suppl. 5), 11.
15. Jaulerry C., Rodriguez J., Brunin F. et al.: "Induction chemotherapy in advanced head and neck tumors: results of two randomized trials". Int. J. Radiat. Oncol. Biol. Phys., 1992, 23, 483.
16. Horiot J. C., Pigneux J., Pourquier H. et al.: "Radiotherapy alone in carcinoma of the intact uterine cervix according to G. H. Fletcher guidelines: a French cooperative study of 1383 cases". Int. J. Radiat. Oncol. Biol. Phys., 1988, 14, 605.
17. Keys H. M., Bundy B. N., Stehman F. B. et al.: "Cisplatin, radiation and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for Bulky stage IB cervical carcinoma". N. Engl. J. Med., 1999, 340, 1154.
18. Kim D., Moon H., Hwang Y. et al.: "Preoperative adjuvant chemotherapy in the treatment of cervical cancer stage Ib, IIa, and IIB with bulky tumor". Gynecol. Oncol., 1987, 29, 321.
19. Kumar L., Kaushal R., Nandy M. et al.: "Chemotherapy followed by radiotherapy versus radiotherapy alone in locally advanced cervical cancer: a randomized study". Gynecol. Oncol., 1994, 54, 307.
20. Landis S. H., Murray T., Bolden S. et al.: "Cancer statistics, 1999". C. A. Cancer J. Clin., 1999, 49, 8.
21. Leborgne F., Leborgne J. H., Doldan R. et al.: "Induction chemotherapy and radiotherapy of advanced cancer of the cervix: a pilot study and phase III randomized trial". Int. J. Radiat. Oncol. Biol. Phys., 1997, 37, 343.
22. Lehman M., Thomas G.: "Is concurrent chemotherapy and radiotherapy the new standard of care for locally advanced cervical cancer?". Int. J. Gynecol. Cancer, 2001, 11, 87.
23. Logsdon M. D., Eifel P. J.: "Figo IIIB squamous cell carcinoma of the cervix: an analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy". Int. J. Radiat. Oncol. Biol. Phys., 1999, 43, 763.
24. Mancuso S., Benedetti P., Greggi S.: "Neoadjuvant chemotherapy in advanced cervical carcinoma". Eur. J. Gynecol. Oncol., 1987, 8, 335.
25. Mazeron J. J., Martin M., Brun B. et al.: "Induction chemotherapy in head and neck cancer: results of a phase III trial". Head Neck, 1992, 14, 85.
26. Merlano M., Benasso M., Corvo R. et al.: "Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck". J. Natl. Cancer Inst., 1996, 88, 583.
27. Morris M., Eifel P. J., Lu J. et al.: "Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer". N. Engl. J. Med., 1999, 340, 1137.
28. National Cancer Institute: "Concurrent chemotherapy for cervical cancer. Clinical announcement", Washington, DC, February 22, 1999.
29. Paccagnella A., Orlando A., Marchiori C. et al.: "Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: a study by the Gruppo di Studio sui Tumori della Testa e del Collo". J. Natl. Cancer. Inst., 1994, 86, 265.
30. Pearcy R., Brundage M., Jeffrey J. et al.: "A clinical trial comparingconcurrent cisplatin and radiation therapy vs. radiation therapy alone for locally advanced squamous cell carcinoma of the cervix acrried out by the National Cancer Institute of Canada Clinical Trials Group". Proc. Am. Soc. Clin. Oncol., 2000, 19, 378 (abstract).
31. Perez C. A., Grigsby P. W., Chao K. S. et al.: "Tumor size, irradiation dose, and long-term outcome of carcinoma of uterine cervix". Int. J. Radiat. Oncol. Biol. Phys., 1998, 41, 307.
32. Richard J. M., Sancho-Garnier H., Pessey J. J. et al.: "Randomized trial of induction chemotherapy in larynx carcinoma". Oral. Oncol., 1998, 34, 224.
33. Roberts K. B., Urdaneta N., Vera R. et al.: "Interim results of a randomized trial of mitomycin C as an adjunct to radical radiotherapy in the treatment of locally advanced squamous-cell carcinoma of the cervix". Int. J. Cancer, 2000, 90, 206.
34. Rose P. G., Bundy B. N., Watkins E. B. et al.: "Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer". N. Engl. J. Med., 1999, 340, 1144.
35. Rosenthal D. I., Pistenmaa D. A., Glatstein E.: "A review of neoadjuvant chemotherapy for head and neck cancer: partially shrunken tumors may be both leaner and meaner". Int. J. Radiat. Oncol. Biol. Phys., 1994, 28, 315.
36. Rustin G. J., Newlands E. S., Southcott B. M. et al.: "Cisplatin, vincristine, methotrexate and bleomycin (POMB) as initial or palliative chemotherapy for carcinoma of the cervix". Br. J. Obstet. Gynaecol., 1987, 94, 1205.
37. Sardi J., Di Paola G., Cachau A. et al.: "A possible new trend in the management of carcinoma of the cervix". Gynecol. Oncol., 1986, 25, 139.
38. Sardi J., Sananes C., Giaroli A. et al.: "Neoadjuvant chemotherapy in locally advanced carcinoma of the cervix uteri". Gynecol. Onco., 1990, 38, 486.
39. Sardi J., Sananes C., Giaroli A. et al.: "Results of a prospective randomized trial with neoadjuvant chemotherapy in stage IB, bulky, squamous carcinoma of the cervix". Gynecol. Oncol., 1993, 49, 156.
40. Sardi J. E., Giaroli A., Sananes C. et al.: "Long-term follow-up of the first randomized trial using neoadjuvant chemotherapy in stage Ib squamous carcinoma of the cervix: the final results". Gynecol. Oncol., 1997, 67, 61.
41. Seoud M., Shamsseddine A., Saghir N. et al.: "Gynecologic registry at the American University of Beirut 1983-1998. The International Gynecologic Society of Cancer (abst.)". September 1999, Rome, Italy.
42. Smith H. O., Stringer C. A., Kavanagh J. J. et al.: "Treatment of advanced or recurrent squamous cell carcinoma of the uterine cervix with mitomycin-C, bleomycin, and cisplatin chemotherapy". Gynecol. Oncol., 1993, 48, 11.
43. Souhami L., Gil R. A., Allan S. E. et al.: "A randomized trial of chemotherapy followed by pelvic radiation therapy in stage IIIB carcinoma of the cervix". J. Clin. Oncol., 1991, 9, 970.
44. Tattersall M. H., Ramirez C., Coppleson M.: "A randomized trial of adjuvant chemotherapy after radical hysterectomy in stage Ib-IIa cervical cancer patients with pelvic lymph node metastases". Gynecol. Oncol., 1992, 46, 176.
45. Tattersall M. H., Lorvidhaya V., Vootiprux V. et al.: "Randomized trial of epirubicin and cisplatin chemotherapy followed by pelvic radiation in locally advanced cervical cancer. Cervical Cancer Study Group of the Asian Oceanian Clinical Oncology Association". J. Clin. Oncol., 1995, 13, 444.
46. Thomas G. M.: "Improved treatment for cervical cancer - concurrent chemotherapy and radiotherapy". N. Engl. J. Med., 1999, 340, 1198.
47. Xu L., Xie K., Mukaida N. et al.: "Hypoxia-induced elevation in interleukin-8 expression by human ovarian carcinoma cells". Cancer Res., 1999, 59, 5822.